Chimerix Inc (NASDAQ:CMRX) - Share price - Overview

Stock Report

Chimerix Inc CMRX

Last Price
$4.63

Day Change
0.07|1.54%

As of 25/05/2018
16:22:20 EDT | USD
Minimum 15 Minutes Delay.

Last Close4.56
Day Range4.47 - 4.64
Mkt Cap221.10Mil
52-Wk Range4.17 - 5.94
Yield %-
ISINUS16934W1062
Volume172,882
P/E-2.99
P/S52.08
P/CF-3.97

Share Price

Financials
201520162017
More ...
Income Statement
Revenue10.765.704.49
Operating Income-118.25-77.95-72.10
Net Income-117.37-76.39-70.98
Basic EPS-2.67-1.65-1.51
Avg. Diluted Shares Outstanding444647
Balance Sheet
Current Assets228.84236.47156.53
Non Current Assets127.1650.3178.70
Total Assets355.99286.77235.23
Current Liabilities20.1810.1113.20
Total Liabilities---
Total Equity335.46276.22221.81
Cash Flow
Operating Cash Flow-99.89-63.82-50.13
Capital Expenditure-2.21-0.84-0.15
Free Cash Flow-102.10-64.66-50.28

In millions, except "Basic EPS". Currency is USD.

Company Profile

Chimerix Inc is a biopharmaceutical company which focuses on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

82
Key Stats
More ...
Price/Earning TTM-2.94
Price/Book1.06
Price/Sales TTM47.65
Rev Growth (3 year avg)3.61
EPS Growth (3 year avg)-
Operating Margin % TTM-1,604.41
Net Margin % TTM-1,579.53
ROE TTM-28.51
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.